Overview

Gene Location [1]
12p13.1
Pathway
Cell cycle control
Gene
CDKN1B

CDKN1B Mutation is present in 0.90% of AACR GENIE cases, with breast carcinoma, colorectal adenocarcinoma, non-small cell lung carcinoma, bladder carcinoma, and prostate cancer having the greatest prevalence [4].

Top Disease Cases with CDKN1B Mutation

Significance of CDKN1B Mutation in Diseases

Malignant Solid Tumor +

Non-Hodgkin Lymphoma +

Breast Carcinoma +

Colorectal Carcinoma +

Bladder Carcinoma +

Lymphoma +

Melanoma +

Anaplastic Astrocytoma +

Esophageal Carcinoma +

Glioblastoma +

Non-Small Cell Lung Carcinoma +

Head And Neck Carcinoma +

Gastric Carcinoma +

Sarcoma +

Pancreatic Carcinoma +

Germ Cell Tumor +

Histiocytic And Dendritic Cell Neoplasm +

Ovarian Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.